Haematological Disease

Haematological Disease

Показать другие версии (1)

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

Полное описание

Библиографические подробности
Главные авторы:	Estcourt, L, Stanworth, S, Murphy, M
Формат:	Book section
Опубликовано:	John Wiley and Sons 2013

Схожие документы

Haematological Disease
по: Murphy, M, и др.
Опубликовано: (2009)

Platelet transfusions for patients with haematological malignancies: who needs them?
по: Estcourt, L, и др.
Опубликовано: (2011)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
по: Estcourt, L, и др.
Опубликовано: (2014)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
по: Estcourt, L, и др.
Опубликовано: (2017)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
по: Estcourt, L, и др.
Опубликовано: (2016)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
по: Wardrop, D, и др.
Опубликовано: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
по: Wardrop, D, и др.
Опубликовано: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
по: Desborough, M, и др.
Опубликовано: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
по: Estcourt, L, и др.
Опубликовано: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
по: Estcourt, L, и др.
Опубликовано: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
по: Estcourt, L, и др.
Опубликовано: (2015)

Prophylactic platelet transfusions
по: Estcourt, L, и др.
Опубликовано: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
по: Estcourt, L, и др.
Опубликовано: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
по: Estcourt, L, и др.
Опубликовано: (2015)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
по: Estcourt, L, и др.
Опубликовано: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
по: Estcourt, L, и др.
Опубликовано: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
по: Estcourt, L, и др.
Опубликовано: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
по: Estcourt, L, и др.
Опубликовано: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
по: Estcourt, L, и др.
Опубликовано: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
по: Stanworth, S, и др.
Опубликовано: (2006)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
по: Estcourt, L, и др.
Опубликовано: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
по: Stanworth, S, и др.
Опубликовано: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
по: Stanworth, S, и др.
Опубликовано: (2014)

2016 National audit of red cell use in adult haematology patients
по: Karakantza, M, и др.
Опубликовано: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
по: Crighton, GL, и др.
Опубликовано: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
по: Butler, C, и др.
Опубликовано: (2011)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
по: Crighton, GL, и др.
Опубликовано: (2021)

Pathogen-reduced platelets for the prevention of bleeding (Review)
по: Estcourt, L, и др.
Опубликовано: (2017)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
по: Estcourt, L, и др.
Опубликовано: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
по: Butler, C, и др.
Опубликовано: (2013)

Pathogen-reduced platelets for the prevention of bleeding.
по: Butler, C, и др.
Опубликовано: (2013)

Transfusion practice and safety: current status and possibilities for improvement.
по: Murphy, M, и др.
Опубликовано: (2011)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
по: Hyde, C, и др.
Опубликовано: (2008)

Evidence for indications of fresh frozen plasma.
по: Stanworth, S, и др.
Опубликовано: (2007)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
по: Hyde, C, и др.
Опубликовано: (2008)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
по: Campbell, H, и др.
Опубликовано: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
по: Campbell, H, и др.
Опубликовано: (2014)

Platelet transfusions in haematology patients: are we using them appropriately?
по: Estcourt, L, и др.
Опубликовано: (2012)

Alternatives to allogeneic platelet transfusion
по: Desborough, M, и др.
Опубликовано: (2016)

Putting clinical trials into context.
по: Hyde, C, и др.
Опубликовано: (2005)